FMC Corporation reports strong growth in third quarter, confirms full-year outlook adjusted for expected sale of GSS business
Volume growth and higher cost savings led to earnings above the high end of guidance range
Third Quarter 2024 Highlights
- Revenue of
$1.07 billion , an increase of 9 percent versus Q3 2023 and up 12 percent organically1 - Consolidated GAAP net income of
$66 million , up$70 million from a net loss of$4 million in Q3 2023 - Adjusted EBITDA of
$201 million , up 15 percent versus Q3 2023 - Consolidated GAAP net income of
$0.52 per diluted share, up$0.55 from a net loss of$0.03 per diluted share in Q3 2023 - Adjusted earnings per diluted share of
$0.69 , up 57 percent versus Q3 2023 - GAAP Cash from operations of
$160 million with free cash flow of$132 million
Full-Year Outlook 2
- Revenue outlook of
$4.33 billion to$4.44 billion , reflecting a 2 percent decline at the midpoint versus 2023; reduced$20 million for loss of contribution from Global Specialty Solutions (GSS) business3 - Adjusted EBITDA outlook range of
$885 million to$915 million , reflecting an 8 percent decline at the midpoint versus 2023; reduced$10 million for loss of contribution from GSS business3 - Adjusted earnings per diluted share outlook range of
$3.16 to$3.52 , reflecting a 12 percent decrease at the midpoint versus 2023 - Increases target restructuring savings range to
$125 million to$150 million of adjusted EBITDA net benefit - Free cash flow outlook range unchanged at
$400 million to$500 million
Third Quarter Adjusted EPS versus |
+25 cents |
Adjusted EBITDA |
+18 cents |
Interest Expense |
|
Depreciation & Amortization |
|
Minority Interest |
- |
Taxes |
+3 cents |
Rounding |
- |
"We delivered revenue and earnings growth as market conditions improved although at varying rates across the regions," said
Revenue growth in the quarter of 9 percent was driven by a 17 percent increase in volume, with some
In
FMC Revenue |
Q3 2024 |
||
Total Revenue Change (GAAP) |
9 % |
||
Less FX Impact |
(3) % |
||
Organic1 Revenue Change (Non-GAAP) |
12 % |
||
|
|
|
|
Third quarter adjusted EBITDA was
Full-Year 2024 Outlook2,3
The company is confirming its full-year 2024 outlook for sales and EBITDA and updating its outlook for adjusted EPS. The midpoints for sales and EBITDA are adjusted for the imminent sale of the GSS business, which is expected to close in early November. Full-year revenue guidance has tightened to be in the range of
Fourth Quarter Outlook2,3
The fourth quarter outlook has been adjusted to reflect the imminent sale of the GSS business (
"We plan to deliver strong fourth quarter growth despite a shift of some second half orders from the fourth quarter into the third quarter, while many countries continue operating in challenging conditions," said Brondeau. "Key fourth quarter earnings growth drivers are robust sales of new products as well as additional cost benefits from our restructuring program. We still expect further earnings growth in 2025 from cost tailwinds as well as moderate top line growth as market conditions improve."
|
Full Year 2024 Outlook2,3 |
Q4 2024 Outlook2,3 |
Revenue |
|
|
Growth at midpoint vs. 2023* |
-2 % |
19 % |
Adjusted EBITDA |
|
|
Growth at midpoint vs. 2023* |
-8 % |
32 % |
Adjusted EPS^ |
|
|
Growth at midpoint vs. 2023* |
-12 % |
54 % |
|
^Adjusted EPS estimates assume 125.3 million diluted shares for Q4 and full year. |
*Percentages are calculated using whole numbers. Minor differences may exist due to rounding. |
Supplemental Information
The company will post supplemental information on the web at investors.fmc.com, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the most directly comparable GAAP term.
Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC, the FMC logo, Cyazypyr and Onsuva are trademarks of
About FMC
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended
We specifically decline to undertake any obligation, and specifically disclaims any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
This press release contains certain "non-GAAP financial terms" which are defined on our website www.fmc.com/investors. Such terms include adjusted EBITDA, adjusted earnings, free cash flow and organic revenue growth. In addition, we have also provided on our website reconciliations of non-GAAP terms to the most directly comparable GAAP term.
- Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes.
- Although we provide forecasts for adjusted earnings per share, adjusted EBITDA, and free cash flow (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, and discontinued operations. As a result, no GAAP outlook is provided.
- Adjusted for anticipated sale of Global Specialty Solutions (GSS) business expected to close in early
November 2024
CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited and in millions, except per share amounts) |
|||||||
|
|||||||
|
Three Months Ended |
|
Nine Months Ended |
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Revenue |
$ 1,065.4 |
|
$ 981.9 |
|
$ 3,021.8 |
|
$ 3,340.7 |
Costs of sales and services |
679.0 |
|
600.7 |
|
1,897.6 |
|
1,945.4 |
Gross margin |
$ 386.4 |
|
$ 381.2 |
|
$ 1,124.2 |
|
$ 1,395.3 |
Selling, general and administrative expenses |
159.2 |
|
171.3 |
|
487.9 |
|
562.8 |
Research and development expenses |
69.0 |
|
80.9 |
|
205.8 |
|
247.0 |
Restructuring and other charges (income) |
22.6 |
|
28.2 |
|
158.6 |
|
48.0 |
Total costs and expenses |
$ 929.8 |
|
$ 881.1 |
|
$ 2,749.9 |
|
$ 2,803.2 |
Income from continuing operations before non-operating pension and |
$ 135.6 |
|
$ 100.8 |
|
$ 271.9 |
|
$ 537.5 |
Non-operating pension and postretirement charges (income) |
4.4 |
|
4.2 |
|
12.9 |
|
13.4 |
Interest expense, net |
58.7 |
|
64.6 |
|
184.0 |
|
180.5 |
Income (loss) from continuing operations before income taxes |
$ 72.5 |
|
$ 32.0 |
|
$ 75.0 |
|
$ 343.6 |
Provision (benefit) for income taxes |
6.0 |
|
27.4 |
|
(298.9) |
|
77.7 |
Income (loss) from continuing operations |
$ 66.5 |
|
$ 4.6 |
|
$ 373.9 |
|
$ 265.9 |
Discontinued operations, net of income taxes |
(0.9) |
|
(8.3) |
|
(16.2) |
|
(41.3) |
Net income (loss) |
$ 65.6 |
|
$ (3.7) |
|
$ 357.7 |
|
$ 224.6 |
Less: Net income (loss) attributable to noncontrolling interests |
0.6 |
|
(0.2) |
|
0.3 |
|
1.6 |
Net income (loss) attributable to FMC stockholders |
$ 65.0 |
|
$ (3.5) |
|
$ 357.4 |
|
$ 223.0 |
Amounts attributable to FMC stockholders: |
|
|
|
|
|
|
|
Income (loss) from continuing operations |
$ 65.9 |
|
$ 4.8 |
|
$ 373.6 |
|
$ 264.3 |
Discontinued operations, net of tax |
(0.9) |
|
(8.3) |
|
(16.2) |
|
(41.3) |
Net income (loss) |
$ 65.0 |
|
$ (3.5) |
|
$ 357.4 |
|
$ 223.0 |
Basic earnings (loss) per common share attributable to FMC stockholders: |
|
|
|
|
|
|
|
Continuing operations |
$ 0.53 |
|
$ 0.04 |
|
$ 2.98 |
|
$ 2.11 |
Discontinued operations |
(0.01) |
|
(0.07) |
|
(0.13) |
|
(0.33) |
Basic earnings per common share |
$ 0.52 |
|
$ (0.03) |
|
$ 2.85 |
|
$ 1.78 |
Average number of shares outstanding used in basic earnings per share computations |
125.0 |
|
124.9 |
|
125.0 |
|
125.1 |
Diluted earnings (loss) per common share attributable to FMC stockholders: |
|
|
|
|
|
|
|
Continuing operations |
$ 0.53 |
|
$ 0.04 |
|
$ 2.98 |
|
$ 2.10 |
Discontinued operations |
(0.01) |
|
(0.07) |
|
(0.13) |
|
(0.33) |
Diluted earnings per common share |
$ 0.52 |
|
$ (0.03) |
|
$ 2.85 |
|
$ 1.77 |
Average number of shares outstanding used in diluted earnings per share computations |
125.5 |
|
125.3 |
|
125.3 |
|
125.7 |
|
|
|
|
|
|
|
|
Other Data: |
|
|
|
|
|
|
|
Capital additions and other investing activities |
$ 13.7 |
|
$ 35.5 |
|
$ 51.5 |
|
$ 116.6 |
Depreciation and amortization expense |
43.2 |
|
45.6 |
|
133.2 |
|
138.4 |
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES |
|||||||
|
|||||||
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS, ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP) (Unaudited and in millions, except per share amounts) |
|||||||
|
|||||||
|
Three Months Ended |
|
Nine Months Ended |
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net income (loss) attributable to FMC stockholders (GAAP) |
$ 65.0 |
|
$ (3.5) |
|
$ 357.4 |
|
$ 223.0 |
Corporate special charges (income): |
|
|
|
|
|
|
|
Restructuring and other charges (income) (a) |
22.6 |
|
28.2 |
|
158.6 |
|
48.0 |
Non-operating pension and postretirement charges (income) (b) |
4.4 |
|
4.2 |
|
12.9 |
|
13.4 |
Income tax expense (benefit) on Corporate special charges (income) (c) |
(5.0) |
|
(4.2) |
|
(28.4) |
|
(8.5) |
Adjustment for noncontrolling interest, net of tax on Corporate special charges (income) |
— |
|
0.4 |
|
— |
|
(1.6) |
Discontinued operations attributable to FMC stockholders, net of income taxes (d) |
0.9 |
|
8.3 |
|
16.2 |
|
41.3 |
Tax adjustment (e) |
(0.7) |
|
22.0 |
|
(305.0) |
|
25.5 |
Adjusted after-tax earnings from continuing operations attributable |
$ 87.2 |
|
$ 55.4 |
|
$ 211.7 |
|
$ 341.1 |
|
|
|
|
|
|
|
|
Diluted earnings per common share (GAAP) |
$ 0.52 |
|
$ (0.03) |
|
$ 2.85 |
|
$ 1.77 |
Corporate special charges (income) per diluted share, before tax: |
|
|
|
|
|
|
|
Restructuring and other charges (income) |
0.18 |
|
0.22 |
|
1.27 |
|
0.39 |
Non-operating pension and postretirement charges (income) |
0.03 |
|
0.03 |
|
0.10 |
|
0.11 |
Income tax expense (benefit) on Corporate special charges (income), per diluted share |
(0.04) |
|
(0.03) |
|
(0.23) |
|
(0.07) |
Adjustment for noncontrolling interest, net of tax on Corporate special charges (income) per diluted share |
— |
|
— |
|
— |
|
(0.02) |
Discontinued operations attributable to FMC stockholders, net of income taxes per diluted share |
0.01 |
|
0.07 |
|
0.13 |
|
0.33 |
Tax adjustments per diluted share |
(0.01) |
|
0.18 |
|
(2.43) |
|
0.20 |
Diluted adjusted after-tax earnings from continuing operations per |
$ 0.69 |
|
$ 0.44 |
|
$ 1.69 |
|
$ 2.71 |
|
|
|
|
|
|
|
|
Average number of shares outstanding used in diluted adjusted after-tax |
125.5 |
|
125.3 |
|
125.3 |
|
125.7 |
____________________
(1) |
Referred to as Adjusted earnings. The Company believes that Adjusted earnings, a Non-GAAP financial measure, and its presentation on a per share basis provides useful information about the Company's operating results to management, investors, and securities analysts. Adjusted earnings excludes the effects of corporate special charges, tax-related adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying business from period to period. |
(a) |
Three Months Ended |
|
Restructuring and other charges (income) includes restructuring charges of |
|
Three Months Ended |
|
Restructuring and other charges (income) includes |
|
Nine Months Ended |
|
Restructuring and other charges (income) includes restructuring charges of |
|
Nine Months Ended |
|
Restructuring and other charges (income) includes |
(b) |
Our non-operating pension and postretirement charges (income) are defined as those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our Adjusted Earnings and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our Adjusted Earnings results noted above. These elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. |
(c) |
The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure. |
(d) |
Discontinued operations includes provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations and retained liabilities. Discontinued operations for the nine months ended |
(e) |
We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to continuing operating results in the current year; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets and related interim accounting impacts; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to continuing operating results thereby providing investors with useful supplemental information about FMC's operational performance. |
|
Three Months Ended |
|
Nine Months Ended |
||||
(in Millions) |
2024 |
|
2023 |
|
2024 |
|
2023 |
Non-GAAP tax adjustments |
|
|
|
|
|
|
|
Revisions to valuation allowances of historical deferred tax assets |
$ — |
|
$ — |
|
$ (1.6) |
|
$ — |
Foreign currency remeasurement and other discrete items |
(0.7) |
|
22.0 |
|
(303.4) |
|
25.5 |
Total Non-GAAP tax adjustments |
$ (0.7) |
|
$ 22.0 |
|
|
|
$ 25.5 |
|
In connection with our plans to establish a global technology and innovation center in |
RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING (Unaudited, in millions) |
|||||||
|
|||||||
|
Three Months Ended |
|
Nine Months Ended |
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net income (loss) (GAAP) |
$ 65.6 |
|
$ (3.7) |
|
$ 357.7 |
|
$ 224.6 |
Restructuring and other charges (income) |
22.6 |
|
28.2 |
|
158.6 |
|
48.0 |
Non-operating pension and postretirement charges (income) |
4.4 |
|
4.2 |
|
12.9 |
|
13.4 |
Discontinued operations, net of income taxes |
0.9 |
|
8.3 |
|
16.2 |
|
41.3 |
Interest expense, net |
58.7 |
|
64.6 |
|
184.0 |
|
180.5 |
Depreciation and amortization |
43.2 |
|
45.6 |
|
133.2 |
|
138.4 |
Provision (benefit) for income taxes |
6.0 |
|
27.4 |
|
(298.9) |
|
77.7 |
Adjusted earnings from continuing operations, before interest, income |
$ 201.4 |
|
$ 174.6 |
|
$ 563.7 |
|
$ 723.9 |
___________________
(1) |
Referred to as Adjusted EBITDA. Defined as operating profit excluding restructuring and other charges (income) and depreciation and amortization expense. |
RECONCILIATION OF CASH PROVIDED (REQUIRED) BY OPERATING ACTIVITIES OF (Unaudited, in millions) |
|||||||
|
|||||||
|
Three Months Ended |
|
Nine Months Ended |
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Cash provided (required) by operating activities of continuing operations (GAAP) |
$ 159.5 |
|
$ 101.6 |
|
$ 308.8 |
|
|
Project Focus transformation spending (1) |
26.4 |
|
— |
|
89.9 |
|
— |
|
|
|
|
|
|
|
|
Capital expenditures |
(15.7) |
|
(33.0) |
|
(46.3) |
|
(108.8) |
Other investing activities |
2.0 |
|
(2.5) |
|
(5.2) |
|
(7.8) |
Capital additions and other investing activities |
$ (13.7) |
|
$ (35.5) |
|
$ (51.5) |
|
|
|
|
|
|
|
|
|
|
Cash provided (required) by operating activities of discontinued operations |
(18.3) |
|
(34.1) |
|
(37.2) |
|
(61.0) |
Project Focus transformation spending (1) |
(26.4) |
|
— |
|
(89.9) |
|
— |
Proceeds from Land Disposition |
— |
|
— |
|
— |
|
5.8 |
Legacy and transformation |
$ (44.7) |
|
$ (34.1) |
|
|
|
$ (55.2) |
|
|
|
|
|
|
|
|
Divestiture transaction costs (2) |
$ 4.6 |
|
$ — |
|
$ 4.6 |
|
$ — |
Free cash flow (Non-GAAP)(3) |
$ 132.1 |
|
$ 32.0 |
|
$ 224.7 |
|
|
___________________
(1) |
Represents cash payments made in connection with our Project Focus transformation program. This spending is reclassified within this reconciliation to be reflected in the "Legacy and transformation" category. The presentation has no impact on our cash provided (required) by operating activities of continuing operations (GAAP) or free cash flow (non-GAAP). |
(2) |
Represents transactional-related costs such as legal and professional third-party fees associated with the anticipated sale of our Global Specialty Solutions ("GSS") business. Proceeds from the sale of our GSS business anticipated for the fourth quarter 2024 will be excluded from free cash flow when received. Therefore, we have also excluded the related transaction costs from free cash flow. |
(3) |
Free cash flow is defined as cash provided (required) by operating activities of continuing operations (GAAP) adjusted for spending for capital additions and other investing activities as well as legacy and transformation spending and divestiture transaction costs associated with the anticipated sale of our GSS business. As noted above, Project Focus transformation spending is reclassified into "Legacy and transformation" for presentation purposes. We believe that this Non-GAAP financial measure provides a useful basis for investors and securities analysts about the cash generated by routine business operations, including capital expenditures, in addition to assessing our ability to repay debt, fund acquisitions and return capital to shareholders through share repurchases and dividends. Our use of free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results under |
RECONCILIATION OF REVENUE CHANGE (GAAP) TO ORGANIC REVENUE CHANGE (NON-GAAP) (1) (Unaudited) |
|||
|
|||
|
Three Months Ended |
|
Nine Months Ended |
Total Revenue Change (GAAP) |
9 % |
|
(10) % |
Less: Foreign Currency Impact |
(3) % |
|
(2) % |
Organic Revenue Change (Non-GAAP) |
12 % |
|
(8) % |
___________________
(1) |
We believe organic revenue growth (non-GAAP) provides management and investors with useful supplemental information regarding our ongoing revenue performance and trends by presenting revenue growth excluding the impact of fluctuations in foreign exchange rates. |
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO RETURN ON INVESTED CAPITAL ("ROIC") NUMERATOR (NON-GAAP) AND ROIC (USING NON-GAAP NUMERATOR)(1) (Unaudited) |
|||
|
|||
|
Twelve Months Ended |
|
|
|
|
|
|
Net income (loss) attributable to FMC stockholders (GAAP) |
$ 1,455.9 |
|
|
Interest expense, net, net of income taxes |
206.1 |
|
|
Corporate special charges (income) |
366.4 |
|
|
Income tax expense (benefit) on Corporate special charges (income) |
(52.7) |
|
|
Discontinued operations attributable to FMC stockholders, net of income taxes |
73.4 |
|
|
Tax adjustments |
(1,497.9) |
|
|
ROIC numerator (Non-GAAP) |
$ 551.2 |
|
|
|
|
|
|
|
|
|
|
Total debt |
$ 4,070.0 |
|
$ 4,115.7 |
Total FMC stockholders' equity |
4,607.8 |
|
3,290.9 |
Total debt and FMC stockholders' equity (GAAP) |
$ 8,677.8 |
|
$ 7,406.6 |
ROIC denominator (2 yr average total debt and FMC stockholders' equity) |
$ 8,042.2 |
|
|
|
|
|
|
ROIC (using Net income (loss) attributable to FMC stockholders (GAAP) as numerator) |
18.10 % |
|
|
ROIC (using Non-GAAP numerator) |
6.85 % |
|
|
___________________
(1) |
We believe ROIC (non-GAAP) provides management and investors with useful supplemental information regarding our utilization of capital provided by both equity and debt as well as our working capital and free cash flow management. |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in millions) |
|||
|
|||
|
|
|
|
Cash and cash equivalents |
$ 416.7 |
|
$ 302.4 |
Trade receivables, net of allowance of |
2,890.5 |
|
2,703.2 |
Inventories |
1,392.1 |
|
1,724.6 |
Prepaid and other current assets |
616.2 |
|
398.9 |
Total current assets |
$ 5,315.5 |
|
$ 5,129.1 |
Property, plant and equipment, net |
869.4 |
|
892.5 |
|
1,517.8 |
|
1,593.6 |
Other intangibles, net |
2,421.7 |
|
2,465.1 |
Deferred income taxes |
1,621.1 |
|
1,336.6 |
Other long-term assets |
473.2 |
|
509.3 |
Total assets |
$ 12,218.7 |
|
$ 11,926.2 |
Short-term debt and current portion of long-term debt |
$ 1,043.2 |
|
$ 934.0 |
Accounts payable, trade and other |
802.9 |
|
602.4 |
Advanced payments from customers |
0.4 |
|
482.1 |
Accrued and other liabilities |
739.3 |
|
684.8 |
Accrued customer rebates |
835.1 |
|
480.9 |
Guarantees of vendor financing |
77.9 |
|
69.6 |
Accrued pensions and other postretirement benefits, current |
6.4 |
|
6.4 |
Income taxes |
83.2 |
|
124.4 |
Total current liabilities |
$ 3,588.4 |
|
$ 3,384.6 |
Long-term debt, less current portion |
$ 3,026.8 |
|
$ 3,023.6 |
Long-term liabilities |
973.4 |
|
1,084.6 |
Equity |
4,630.1 |
|
4,433.4 |
Total liabilities and equity |
$ 12,218.7 |
|
$ 11,926.2 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in millions) |
|||
|
|||
|
Nine Months Ended |
||
|
2024 |
|
2023 |
Cash provided (required) by operating activities of continuing operations |
$ 308.8 |
|
$ (618.2) |
|
|
|
|
Cash provided (required) by operating activities of discontinued operations |
(37.2) |
|
(61.0) |
|
|
|
|
Cash provided (required) by investing activities of continuing operations |
(55.9) |
|
(126.8) |
|
|
|
|
Cash provided (required) by financing activities of continuing operations |
(101.5) |
|
562.1 |
|
|
|
|
Effect of exchange rate changes on cash |
0.1 |
|
(4.3) |
|
|
|
|
Increase (decrease) in cash and cash equivalents |
$ 114.3 |
|
$ (248.2) |
|
|
|
|
Cash and cash equivalents, beginning of period |
$ 302.4 |
|
$ 572.0 |
|
|
|
|
Cash and cash equivalents, end of period |
$ 416.7 |
|
$ 323.8 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-reports-strong-growth-in-third-quarter-confirms-full-year-outlook-adjusted-for-expected-sale-of-gss-business-302290484.html
SOURCE